Why does NTRK2 show minimal association with suicidality despite being the primary BDNF receptor?

OPEN

Previous meta-analyses established BDNF gene associations with suicidal behaviors, yet NTRK2 (encoding BDNF's main receptor TrkB) shows no significant association. This contradiction suggests unknown regulatory mechanisms or pathway complexity that could inform therapeutic targeting. Gap type: contradiction Source paper: Association of NTRK2 gene with suicidality: a meta-analysis. (2024, Psychiatric genetics, PMID:39527116)

Priority: 0.77 Domain: neuropsychiatry Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: Why does NTRK2 show minimal association with suicidality despite being the primary BDNF receptor? is a 0.77 priority gap in neuropsychiatry. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Why does NTRK2 show minimal association with suicidality despite being the primary BDNF receptor? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (31)

H4NTRK2EXERCISEBDNFOXIDATIVE STRESSBDNFBDNFTumorNEURODEGENERATIONBDNF
▸ Show 26 more

associated with (11)

ALZHEIMER'S DISEASEBDNFBDNFHIPPOCAMPUSBDNFNEURODEGENERATIONBDNFDEPRESSIONBDNFAls
▸ Show 6 more

enhances release (1)

H4BDNF

expressed in (1)

BDNFAls

inhibits (1)

BDNFAls

protects against (1)

BDNFNeurodegeneration

regulates (2)

BDNFDepressionBDNFAls

therapeutic target (2)

BDNFDepressionBDNFDEPRESSION
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps